Yuichi Toriyama
About
In The Last Decade
Yuichi Toriyama
31 papers receiving 704 citations
Peers
Comparison fields: 5 of 60
- Ophthalmology 530
- Radiology, Nuclear Medicine and Imaging 445
- Molecular Biology 115
- Cellular and Molecular Neuroscience 105
- Biomedical Engineering 69
Countries citing papers authored by Yuichi Toriyama
This map shows the geographic impact of Yuichi Toriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Toriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Toriyama more than expected).
Fields of papers citing papers by Yuichi Toriyama
This network shows the impact of papers produced by Yuichi Toriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Toriyama. The network helps show where Yuichi Toriyama may publish in the future.
Co-authorship network of co-authors of Yuichi Toriyama
This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Toriyama. A scholar is included among the top collaborators of Yuichi Toriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Toriyama. Yuichi Toriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 6 | |
| 3 | Evaluation of wide-field OCT angiography using Xephilio OCT-S1 for detecting retinal neovascularization in eyes with proliferative diabetic retinopathy | 2 |
| 4 | 33 | |
| 5 | One year follow-up data on changes in aqueous VEGF levels in eyes with diabetic macula edema treated with ranibizumab using the pro re nata regimen | 1 |
| 6 | 16 | |
| 7 | 50 | |
| 8 | 9 | |
| 9 | 93 | |
| 10 | 26 | |
| 11 | 91 | |
| 12 | Changes in aqueous concentrations of various cytokines after intravitreal ranibizumab for diabetic macular edema. | 1 |
| 13 | 18 | |
| 14 | 14 | |
| 15 | 29 | |
| 16 | 22 | |
| 17 | 26 | |
| 18 | 12 | |
| 19 | 18 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.